Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases

S M Goddu, A Bishayee, L G Bouchet, W E Bolch, D V Rao, R W Howell
2000 Journal of Nuclear Medicine  
Several bone-seeking radiopharmaceuticals, such as 32P-orthophosphate, 89Sr-chloride, 186Re-1,1 hydroxyethylidene diphosphonate (HEDP), and 153Sm-ethylene diamine tetramethylene phosphonic acid (EDTMP), have been used to treat bone pain. The major limiting factor with this modality is bone marrow toxicity, which arises from the penetrating nature of the high-energy beta particles emitted by the radionuclides. It has been hypothesized that marrow toxicity can be reduced while maintaining
more » ... tic efficacy by using radionuclides that emit short-range beta particles or conversion electrons. In view of the significant clinical experience with 32P-orthophosphate, and the similarity in pain relief afforded by 32P-orthophosphate and 89Sr-chloride, this hypothesis is examined in this study using 32P- and 33P-orthophosphate in a mouse femur model.
pmid:10809212 fatcat:rbb4skvoyvgs7buzjtojy3eozm